Related Experiment Video

Updated: Aug 17, 2026

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

Chlamydia pneumoniae and atherosclerosis: from Koch postulates to clinical trials

Catherine Liu1, David D Waters

  • 1Division of Cardiology, Department of Medicine, San Francisco General Hospital, University of California, 94110, USA.

Progress in Cardiovascular Diseases
|July 2, 2005
PubMed

Insights

Chlamydia pneumoniae infection is investigated as a cause of atherosclerosis. Evidence from seroepidemiologic, histopathologic, and animal studies, alongside clinical trials, is reviewed to determine its role in coronary artery disease.

Area of Science:

  • Cardiovascular Science
  • Infectious Disease Epidemiology
  • Microbiology

Background:

  • Atherosclerosis is recognized as an inflammatory condition.
  • Infectious agents are being explored for their role in coronary artery disease pathogenesis.
  • Chlamydia pneumoniae is a widely studied pathogen in this context.

Purpose of the Study:

  • To review the evidence for and against Chlamydia pneumoniae infection contributing to atherosclerosis.
  • To analyze the role of this pathogen in coronary artery disease development.

Main Methods:

  • Examination of seroepidemiologic studies.
  • Review of histopathologic findings.
  • Analysis of animal models applying Koch's postulates.
  • Evaluation of current clinical trial data.

Main Results:

  • The paper synthesizes diverse data to assess Chlamydia pneumoniae's link to atherosclerosis.
  • Koch's postulates are used as a framework for evaluating causality.
  • Clinical trial outcomes are analyzed for their implications.

Conclusions:

  • The review provides a comprehensive assessment of Chlamydia pneumoniae's involvement in atherosclerosis.
  • The findings contribute to understanding infectious triggers of coronary artery disease.
  • Further research may clarify the pathogen's definitive role.

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...